Expression of endothelin-1, and endothelin A and B receptors in portal hypertensive esophagus of rats

Journal of Physiology and Pharmacology

Volumn 51, Issue 1, 2000, Pages 57-67

  Ohta, M ^a,b,c   Pai, R ^a,b   Kawanaka, H ^a,b,c   Ma, T ^a,b   Sugimachi, K ^c   Sarfeh, I J ^a,b   Tarnawski, Andrzej S ^a,b,d,e  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KYUSHU UNIVERSITY   (Japan)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e NONE   (United States)

Author keywords

Endothelin receptor; Endothelin 1; Esophageal varices; Portal hypertension

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ESOPHAGUS; NONHUMAN; PORTAL HYPERTENSION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ENDOTHELIN-1; ESOPHAGUS; HYPERTENSION, PORTAL; MUCOUS MEMBRANE; PORTAL VEIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; RNA, MESSENGER; VENOUS PRESSURE;

EID: 0034108774     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Groszmann RJ, Vorobioff J, Riley E. Portal hypertension. In: The Liver Biology and Pathobiology. IM Arias, WB Jacoby, H Popper, et al. (eds). 2nd Ed. New York: Raven Press. 1988, pp. 1147-1159.
2. Vane JR, Botting RM. Secretory functions of the vascular endothelium. J Physiol Pharmacol 1992; 43: 195-207.
3. Pizcueta P, Pique JM, Bosch J, et al. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation changes of rats with portal hypertension. Br J Pharmacol 1992; 105: 184-190.
4. Pizcueta P, Pique JM, Fernandez M, et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992; 103: 1909-1915.
5. Tanoue K, Ohta M, Tarnawski AS, et al. Portal hypertension activates the nitric oxide synthase genes in the esophageal mucosa of rats. Gastroenterology 1996; 110: 549-557.
6. Levin ER. Mechanisms of disease. Endothelin. N Engl J Med 1995; 333: 356-363.
7. Arai H, Hori S, Aramori I, et al. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990; 348: 730-732.
8. Hirata Y, Emori T, Eguchi S, et al. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 1993; 91: 1367-1373.
9. de Nucci G, Thomas R, D'Orleans-Juste P, et al. Presser effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85: 9797-9800.
10. Whittle BJ, Lopez-Belmonte J. Rees DD. Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br J Pharmacol 1989; 98: 646-652.
11. Ohlstein EH, Arleth A, Bryan H, et al. The selective endothelin ETA receptor antagonist BQ-123 antagonizes endothelin-1-mediated mitogenesis. Eur J Pharmacol 1992; 225: 347-350.
12. Eguchi S, Hirata Y, Imai T, et al. Phenotype change of endothelin receptor subtype in cultured rat vascular smooth muscle cells. Endocrinology 1994; 134: 222-228.
13. Takahashi K, Jones PM, Kanse SM, et al. Endothelin in gastrointestinal tract. Presence of endothelinlike immunoreactivity, endothelin-1 messenger RNA, endothelin receptors, and pharmacological effect. Gastroenterology 1990; 99: 1660-1667.
14. Sarfeh IJ, Tarnawski A, Malki A, et al. Portal hypertension and gastric mucosal injury in rats: effects of alcohol. Gastroenterology 1983; 84: 987-993.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidiniumthiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
16. Ausubel FM, Brent R, Kingston RE, et al. Current protocols in Molecular Biology New York, John Willey & Sons. Vol. 2 1994.
17. Sakurai T, Yanagisawa M, moue A, et al. cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem Biophys Res Commun 1991; 175: 44-47.
18. Terada Y, Tomita K, Nonoguchi H, et al. Expression of endothelin-3 mRNA along rat nephron segments using polymerase chain reaction. Kidney Int 1993; 44: 1273-1280.
19. Wang X, Douglas SA, Louden C, et al. Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. Circ Res 1996; 78: 322-328.
20. Lin HY, Kaji EH, Winkel GK, et al. Cloning and functional expression of a vascular smooth muscle endothelin-1 receptor. Proc Natl Acad Sci USA 1991; 88: 3185-3189.
21. Sakurai T, Yanagisawa M, Takuwa Y, et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990; 348: 732-735.
22. Tso JY, Sun XH, Kao TH, et al. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985; 13: 2485-2502.
23. Tarnawski A, Stachura J, Durbin T, et al. Increased expression of epidermal growth factor receptor during gastric ulcer healing in rats. Gastroenterology 1992; 102: 695-698.
24. Suzuki N, Matsumoto H, Kitada C, et al. A sensitive sandwich-enzymeimmunoassay for human endothelin. J Immunol Methods 1989; 118: 245-250.
25. Smith PK Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76-85.
26. Fleiss, JL. The Bonferroni criterion for multiple comparisons. In: The design and analysis of clinical experiments. New York, Wiley. 1986, pp.103-107.
27. Uchihara M, Izumi N, Sato C, et al. Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Hepatology 1992; 16: 95-99.
28. Isobe H, Satoh M, Sakai H, et al. Increased plasma endothelin-1 levels in patients with cirrhosis and esophageal varices. J Clin Gastroenterol 1993; 17: 227-230.
29. Matsumoto H, Uemasu J, Kitano M, et al. Clinical significance of plasma endothelin-1 in patients with chronic liver disease. Dig Dis Sd 1994; 39: 2665-2670.
30. Gerbes AL, Moller S, Gulberg V, et al. Endothelin-1 and -3 plasma concentration in patients with cirrhosis: role of splanchnic and renal passage and liver function. Hepatology 1995; 21: 735-739.
31. Leivas A, Jmenez W, Lamas S, et al. Endothelin 1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites. Gastroenterology 1995; 108: 1842-1848.
32. Hartleb M, Moreau R, Cailmail S, et al. Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis. Gastroenterology 1994; 107: 1085-1093.
33. Yoshimoto S, Ishizaki Y, Sasaki T, et al. Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells. Stroke 1991; 22: 378-383.
34. Whittle BJR, Esplugues JV. Induction of rat gastric damage by the endothelium-derived peptide, endothelin. Br J Pharmacol 1988; 95: 1011-1013.
35. Lazaratos S, Kashimura H, Nakahara A, et al. Gastric ulcer induced by submucosal injection of ET-1: role of potent vasoconstriction and intraluminal acid. Am J Physiol 1993; 265: 6491-6498.
36. Kuchan MJ, Frangos JA. Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am J Physiol 1993; 264: H150-H156.
37. Li H, Chen SJ, Chen YF, et al. Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J Appl Physiol 1994; 77: 1451-1459.
38. Li H, Elton TS, Chen YF, et al. Increased endothelin receptor gene expression in hypoxic rat lung. Am J Physiol 1994; 266: L553-L560.
39. Marsden PA, Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNF-α. Am J Physiol 1992; 262: C854-C861.
40. Newman P, Kakkar W, Kanse SM. Modulation of endothelia receptor expression in human vascular smooth muscle cells by interleukin-1β. FEBS Lett 1995: 363: 161-164.
41. Panes J, Perry MA, Anderson DC, et al. Portal hypertension enhances endotoxin-nduced intracellular adhesion molecule 1 up-regulation in the rat. Gastroenterology 1996; 110: 866-874.
42. Mitaka C, Hirata Y, Ichikawa K, et al. Effects of TNF-α on hemodynamic changes and circulating endothelium-derived vasoactive factors in dogs. Am J Physiol 1994; 267: H 1530-H 1536.
43. Lopez-Talavera JC, Merrill WW, Groszmann RJ. Tumor necrosis factor α: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology 1995; 108: 761-767.
44. Lopez-Talavera JC, Cadelina G, Olchowski J, et al. Thalidomide inhibits tumor necrosis factor a, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats. Hepatology 1996; 23: 1616-1621.
45. Ohta M, Tarnawski AS, Itani R, et al. Tumor necrosis factor a regulates nitric oxide synthase expression in portal hypertensive gastric mucosa of rats Hepatology 1998; 28: 906-913.
46. Tanoue K, Tarnawski AS, Santos AM, et al. Reduced expression of basic fibroblast growth factor and its receptor mRNAs and proteins in portal hypertensive esophageal mucosa: a mechanism responsible for muscularis mucosae thinning and variceal rupture. Surgery 1996; 119: 424-430.
47. Tanoue K, Tarnawski A, Hanke S, et al. Extracellular matrix abnormalities in portal hypertensive esophageal mucosa: the key to variceal rupture? In: Collegium Internationale Chirurgiae Digestivae: 14th World Congress. EJr Passaro, RE Condon, A Basoli (eds) Bologna, Monduzzi Editore. 1994, pp. 109-112.